Specialty Drug, Specialty HUBs, Specialty Pharmacy
PantherRx Rare and Orsini Specialty Pharmacy Chosen as Partners for OXLUMO
08
Dec
Dec
Alnylam® Pharmaceuticals selected PantherRx Rare and Orsini Specialty Pharmacy as limited distribution partners for OXLUMO™ (lumasiran). OXLUMO is the first and only treatment approved for primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients. PH1 is an ultra-rare genetic disease characterized by the overproduction of oxalate, a waste product that […]
